 The Company's mission is to revolutionize the biomanufacturing industry by providing comprehensive GMP manufacturing solutions that are flexible, less expensive to build and maintain, and easier to operate than any existing solution. 
|
Dr. Barry Holtz, President of G-Con, is a recognized international expert in design and construction of biotherapeutic facilities. David Haselwood, an experienced life science entrepreneur, investor and operator, heads up business operations for G-Con. Together they lead a team with the resources and experience to perform research and development, implement bioprocesses, assure regulatory compliance, successfully interact with regulatory and governmental agencies and conduct clinical trials. The Company maintains an integrated product team of engineers with bioprocess development, mechanical-electrical, and heating, ventilation, and air conditioning (HVAC) experience. We manufacture all of our Pods 55,000 square foot manufacturing facilities. We currently have the capacity to build over 200 Pods per year. The manufacturing space includes a design and engineering facility. |
